In addition, several current chemotherapeutic agents (indicated in blue) such as epirubicin hydrochloride, dactinomycin, daunorubicin and doxorubicin were identified which suggests that anti‐cancer drugs currently in use may be functioning, in part, through targeting TBX2/3 levels (Livshits, Rao, and Smith 2014). Here, TBX2 is linked to cancer.